Network·Venture Capital
📍 Trondheim, Norway
APIM Therapeutics AS is a venture-capital financed biotech spin-off from Norwegian University of Science and Technology (NTNU) developing first-in-class peptide drug candidates targeting PCNA-dependent stress responses in cancer cells.
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Location
Trondheim, Norway
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.